Paratek Pharmaceuticals Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
427
- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
21
- Investments
-
3
Paratek Pharmaceuticals General Information
Description
Developer of antibacterial products intended to treat infectious diseases and improve patient outcomes. The company offers therapies based on advanced tetracycline chemistry, including omadacycline for pneumonia and skin infections, and sarecycline for acne and rosacea, enabling patients with bacterial and inflammatory conditions to achieve better clinical results and improved quality of life.
Contact Information
Website
www.paratekpharma.comCorporate Office
- 1000 First Avenue
- Suite 200
- King of Prussia, PA 19406
- United States
Corporate Office
- 1000 First Avenue
- Suite 200
- King of Prussia, PA 19406
- United States
Paratek Pharmaceuticals Timeline
Paratek Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Paratek Pharmaceuticals Comparisons
Industry
Financing
Details
Paratek Pharmaceuticals Competitors (72)
One of Paratek Pharmaceuticals’s 72 competitors is Neuren Pharmaceuticals, a Corporation company based in Melbourne, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuren Pharmaceuticals | Corporation | Melbourne, Australia | ||||
| Mesoblast | Corporation | Melbourne, Australia | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Amyndas Pharmaceuticals | Accelerator/Incubator Backed | Jackson, WY | ||||
| Bugworks Research | Private Equity-Backed | Wilmington, DE |
Paratek Pharmaceuticals Patents
Paratek Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021288202-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| CA-3179596-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| EP-4165016-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| EP-4165016-A4 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| JP-2026067882-A | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | C07C231/24 |
Paratek Pharmaceuticals Signals
Paratek Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Paratek Pharmaceuticals Investments & Acquisitions (3)
Paratek Pharmaceuticals’s most recent deal was a Buyout/LBO with Radius Health. The deal was made on 16-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Radius Health | 16-Mar-2026 | Buyout/LBO | Pharmaceuticals | ||
| OptiNose | 21-May-2025 | Buyout/LBO | Drug Delivery | ||
| Transcept Pharmaceuticals | 30-Oct-2014 | Merger/Acquisition | Drug Delivery |
Paratek Pharmaceuticals Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| OptiNose | PA | 2010 | |
| Radius Health | Boston, MA | 2003 |
Paratek Pharmaceuticals FAQs
-
When was Paratek Pharmaceuticals founded?
Paratek Pharmaceuticals was founded in 1996.
-
Where is Paratek Pharmaceuticals headquartered?
Paratek Pharmaceuticals is headquartered in King of Prussia, PA.
-
What is the size of Paratek Pharmaceuticals?
Paratek Pharmaceuticals has 427 total employees.
-
What industry is Paratek Pharmaceuticals in?
Paratek Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Paratek Pharmaceuticals a private or public company?
Paratek Pharmaceuticals is a Private company.
-
What is Paratek Pharmaceuticals’s current revenue?
The current revenue for Paratek Pharmaceuticals is .
-
How much funding has Paratek Pharmaceuticals raised over time?
Paratek Pharmaceuticals has raised $1.57B.
-
Who are Paratek Pharmaceuticals’s investors?
REPAIR Impact Fund, B-FLEXION Life Sciences, Novo Holdings, and CBC Group (Singapore) have invested in Paratek Pharmaceuticals.
-
Who are Paratek Pharmaceuticals’s competitors?
Neuren Pharmaceuticals, Mesoblast, The Zambon Group, Amyndas Pharmaceuticals, and Bugworks Research are some of the 72 competitors of Paratek Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process